GL1X · GenesisL1 explorer

MolNFT v1 · #153102 · protein

Crystal structure of human dhodh in complex with inhibitor 1291

6J3C · Dihydroorotate dehydrogenase (quinone), mitochondrial: “Crystal structure of human dhodh in complex with inhibitor 1291”. X-ray diffraction, 4 ligands (FMN, ORO, B5X), 4 pockets (best druggability 0.85). MolNFT v1 #153102 on…

PDB
6J3C
Type
protein
Length
363 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, B5X, SO4
Pockets
4 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein36347% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • B5X · (6R)-1-[4-[3-(dimethylamino)phenyl]-3,5-bis(fluoranyl) phenyl]-6-propan-2-yl-6,7-dihydro-5H-benzotriazol-4-one · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • LDA · Lauryl dimethylamine-N-oxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14340.850.9262FMN, ORO, B5X
21070.450.7920empty
3690.430.8117SO4
4710.340.7616empty

Compared structures

  • 6J3C · Crystal structure of human DHODH in complex with inhibitor 1291 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.